24/7 MN – (NASDAQ: AKAN) shares are moving up more than 44% this morning, on news it plans to supply tetra for FDA trials. Shares are at $1.13 in pre-market trading. More than 11,000 trades have gone off on more than 3.7 million in volume

July 12, 2022

[mstock id=”73007″ asset=”akan”]

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug

https://www.businesswire.com/news/home/20220712005519/en/Akanda-to-Supply-Tetra-Bio-Pharma-with-Pharmaceutical-Grade-Cannabis-for-FDA-Trials-of-QIXLEEF%E2%84%A2-a-Potential-Multimillion-Dollar-Prescription-Drug

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.